Chinese herbal medicine composition having a function of relieving hypothyroidism, preparation method and use thereof

US2018369308A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2018369308-A1
Application numberUS-201816015660-A
CountryUS
Kind codeA1
Filing dateJun 22, 2018
Priority dateJun 26, 2017
Publication dateDec 27, 2018
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to the field of health care product and food technology, disclosing a Chinese herbal medicine composition having a function of relieving hypothyroidism, and preparation method and use thereof. The Chinese herbal medicine composition described in the present disclosure, in parts by weight, comprises: 10 to 100 parts of GINSENG RADIX ET RHIZOMA, 10 to 100 parts of LYCII FRUCTUS, and 6 to 60 parts of CINNAMOMI CORTEX. The Chinese herbal medicine composition described in the present disclosure adopts GINSENG RADIX ET RHIZOMA, LYCII FRUCTUS and CINNAMOMI CORTEX as starting materials, creates synergistic effects through rational combination. Experiments indicate that the Chinese herbal medicine composition described in the present disclosure can improve functions of the thyroid gland in rat hypothyroidism model, reduce serum VEGF level in the model, showing a function of relieving hypothyroidism and protecting the thyroid gland.

First claim

Opening claim text (preview).

What is claimed is: 1 . A Chinese herbal medicine composition, in parts by weight, comprising 10 to 100 parts of GINSENG RADIX ET RHIZOMA, 10 to 100 parts of LYCII FRUCTUS, and 6 to 60 parts of CINNAMOMI CORTEX. 2 . The composition according to claim 1 , wherein, in parts by weight, the composition is made from 20 to 80 parts of GINSENG RADIX ET RHIZOMA, 20 to 80 parts of LYCII FRUCTUS, and 12 to 48 parts of CINNAMOMI CORTEX. 3 . The composition according to claim 1 , wherein, in parts by weight, the composition is made from 30 to 70 parts of GINSENG RADIX ET RHIZOMA, 30 to 70 parts of LYCII FRUCTUS, and 18 to 42 parts of CINNAMOMI CORTEX. 4 . A method for preparing the composition according to claim 1 , comprising: mixing GINSENG RADIX ET RHIZOMA, LYCII FRUCTUS and CINNAMOMI CORTEX as starting materials, extracting by adding water, and filtering and collecting the extract. 5 . The method according to claim 4 , wherein the weight of the added water is 8 to 12 times the weight of the starting materials. 6 . The method according to claim 4 , wherein the temperature of the extraction is 100° C., the duration of the extraction is 1.5 h to 2.5 h, the times of the extraction is 2 to 3. 7 . The method according to claim 4 , further comprising a concentration step, wherein the concentration is conducted by concentrating the extract 8 to 12 folds. 8 . A method for relieving hypothyroidism and/or protecting functions of the thyroid gland, comprising administering the composition according to claim 1 to a subject in need thereof. 9 . The composition according to claim 1 , which is in the form of a health care product. 10 . The composition according to claim 9 , which is in the form of a solid preparation or a liquid preparation; wherein the solid preparation is a tablet, a capsule, a granule, a pill, a dropping pill, a mixture or a power preparation; and the liquid preparation is an oral liquid, a soft capsule or an aerosol preparation.

Assignees

Inventors

Classifications

  • of the thyroid hormones, e.g. T3, T4 · CPC title

  • A61K36/258Primary

    Panax (ginseng) · CPC title

  • using water, e.g. cold water, infusion, tea, steam distillation or decoction · CPC title

  • Lauraceae (Laurel family), e.g. cinnamon or sassafras · CPC title

  • Lycium (desert-thorn) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2018369308A1 cover?
The present disclosure relates to the field of health care product and food technology, disclosing a Chinese herbal medicine composition having a function of relieving hypothyroidism, and preparation method and use thereof. The Chinese herbal medicine composition described in the present disclosure, in parts by weight, comprises: 10 to 100 parts of GINSENG RADIX ET RHIZOMA, 10 to 100 parts of L…
Who is the assignee on this patent?
Infinitus China Co Ltd
What technology area does this patent fall under?
Primary CPC classification A61K36/258. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Dec 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).